Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 209
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03057366 | A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors | ||
| NCT01659658 | Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis | ||
| NCT00931918 | Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients | ||
| NCT01318902 | Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis | ||
| NCT02627677 | A Study Comparing Ponatinib and Nilotinib in Participants With Chronic Myeloid Leukemia | ||
| NCT03870555 | A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-954 in Healthy Adult Participants | ||
| NCT03708211 | A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors | ||
| NCT07240168 | CurQD as Add-On Therapy in Vedolizumab-Treated Ulcerative Colitis Patients: Retrospective Cohort Study | ||
| NCT04563520 | SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis | ||
| NCT03268941 | A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG) | ||
| NCT01663220 | Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus | ||
| NCT02625259 | A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants | ||
| NCT07123350 | Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease | ||
| NCT01418781 | CLinical Prediction Rule Score in Veterans | ||
| NCT00904046 | Pathophysiology of Uric Acid Nephrolithiasis | ||
| NCT03312894 | Efficacy and Safety of TAK-653 in Treatment-Resistant Depression | ||
| NCT02202759 | A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal Junction | ||
| NCT01898078 | Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas | ||
| NCT03701555 | A Study of PVP001, PVP002, and PVP003 in Healthy Adults and PVP001 and PVP002 in Adults With Celiac Disease | ||
| NCT01085643 | Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS) | ||
| NCT00697346 | Study of MLN8237 in Participants With Advanced Hematological Malignancies | ||
| NCT01799850 | The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle | ||
| NCT03965624 | Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia | ||
| NCT01536457 | Reflux Disease Therapy in the Management of Childhood Asthma-data Entry and Analysis Only | ||
| NCT00753623 | Clinical Management of Neuropathic Pain With Ramelteon | ||
| NCT01844583 | Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib | ||
| NCT00619125 | Proposal Evaluating Time-specific Relationships Between Variables of Pain, Stress, and Bloating in IBS Diarrhea and Constipation Symptoms Using a Palm Pilot | ||
| NCT01714947 | Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib | ||
| NCT01094288 | A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen | ||
| NCT04051827 | Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) | ||
| NCT00835120 | Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance | ||
| NCT01990534 | A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma | ||
| NCT01091428 | Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer | ||
| NCT00830518 | A Phase 2 Trial of MLN8237 in Adult Participants With Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome | ||
| NCT04121078 | A Study to Evaluate the Effect of Single-Dose Intravenous Rifampin as a Prototypic Inhibitor of Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 on the Single-Dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants | ||
| NCT04119336 | Nivolumab, Ixazomib, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Myeloma | ||
| NCT03724916 | A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE) | ||
| NCT01888237 | High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication | ||
| NCT01328392 | Evaluating Treatment Response in Laryngo-Pharyngeal Reflux | ||
| NCT01850524 | IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma | ||
| NCT02045095 | A Dose Escalation Study of MLN7243 (TAK-243) in Adult Participants With Advanced Solid Tumors | ||
| NCT01449370 | Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced Cancer | ||
| NCT03283917 | Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis | ||
| NCT02610777 | An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML) | ||
| NCT00161707 | Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency | ||
| NCT00227110 | Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH) | ||
| NCT03449030 | A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC) | ||
| NCT00746395 | Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy | ||
| NCT00963820 | Study Evaluating the Safety and Tolerability of Weekly Dosing of Oral IXAZOMIB in Adult Patients With Relapsed and Refractory Multiple Myeloma | ||
| NCT01425008 | Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma |
